GE HealthCare Technologies Inc. (GEHC) Expands Healthcare Technology Offerings

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best medical technology stocks to invest in. On February 12, GE HealthCare Technologies Inc.’s (NASDAQ:GEHC) board declared a $0.035 per share cash dividend Q1 2026. The dividend will be disbursed on May 15, 2026, to shareholders of record as of April 3, 2026. This dividend amount is unchanged since Q4 2025.

Meanwhile, GE HealthCare announced the US launch of ReadyFix on February 9. ReadyFix is a remote fleet management solution designed to help healthcare systems monitor and support uptime for connected medical devices. The system collects real-time device data to enable remote diagnostics, repair, proactive maintenance and performance optimization, said GE HealthCare. The company added that the solution allows biomedical engineering teams to deploy standardized clinical configurations by department. They can schedule and install software updates remotely, and access diagnostic tools and logs without being physically present at each device’s location.

According to GE HealthCare, ReadyFix is intended to reduce device disruptions and downtime. As such, it will help maintain continuity of cardiac care by supporting consistent performance of ECG workstations used for heart monitoring and diagnostic readings.

GE HealthCare’s management noted that this launch is timely considering the increasing complexity in hospital device fleets. Biomedical teams may manage large numbers of connected devices and face operational strain from maintenance workloads, management stated.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) designs, develops, and manufactures medical technology, pharmaceutical diagnostics, and digital solutions. Its portfolio includes diagnostic imaging systems, ultrasound devices, patient monitoring equipment, imaging agents used in medical scanning, and healthcare IT platforms.

While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the